eXoZymes
(NASDAQ) EXOZ
eXoZymes Financials at a Glance
Market Cap
$70.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$9.67M
EPS (TTM)
-$1.15
P/E Ratio
-6.60
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$7.55
Volume
5,968.34
Open
$7.82
Price
$7.55
Volume
5,968.34
Open
$7.82
Previous Close
$7.55
Daily Range
$7.55 - $7.98
52-Week Range
$6.33 - $18.40
Estimated Earnings Date
Mar 31, 2026
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$7.55
Volume
5,968.34
Open
$7.82
Previous Close
$7.55
Daily Range
$7.55 - $7.98
52-Week Range
$6.33 - $18.40
Estimated Earnings Date
Mar 31, 2026
EXOZ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout eXoZymes
Industry
Biotechnology
Sector
Health CareEmployees
32
CEO
Michael Heltzen
Website
exozymes.comHeadquarters
Monrovia, CA 91016, US
EXOZ Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-220.64%
Return on Capital
-209.38%
Return on Assets
-240.68%
Earnings Yield
-15.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$70.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
9.28M
Volume
5.97K
Avg. Volume
8.11K
Financials (TTM)
Gross Profit
-$3.64K
Operating Income
-$10.15M
EBITDA
-$9.84M
Operating Cash Flow
-$6.89M
Capital Expenditure
-$196.47K
Free Cash Flow
-$7.09M
Cash & ST Invst.
$1.44M
Total Debt
$1.16M
eXoZymes Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$74.15K
-5.2%
Gross Margin
0.00%
N/A
Market Cap
$70.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.27M
N/A
Employees
31
N/A
Net Income
-$2.37M
-27.7%
EBITDA
-$2.30M
-28.6%
Quarterly Fundamentals
Total Cash
$1.44M
-83.0%
Total Debt
$1.16M
-12.2%
Accounts Receivable
$302.86K
-49.1%
Inventory
$0.00
N/A
Long Term Debt
$829.98K
-23.8%
Short Term Debt
$334.90K
+41.4%
Return on Assets
-2.41%
N/A
Return on Invested Capital
-4.17%
N/A
Free Cash Flow
-$1.58M
-35.8%
Operating Cash Flow
-$1.52M
-34.5%